What is the recommended dosing for impetigo in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For pediatric impetigo treatment, oral cephalexin is recommended at 25-50 mg/kg/day divided into 3-4 doses for 7 days, as stated in the 2014 update by the Infectious Diseases Society of America 1. This recommendation is based on the most recent and highest quality evidence available. The dosage of cephalexin is weight-based, and it is essential to follow the recommended dosage to ensure accurate treatment.

  • Alternative treatment options include amoxicillin-clavulanate at 25 mg/kg/day of the amoxicillin component in 2 divided doses for 7 days, as well as topical treatment with mupirocin 2% ointment applied three times daily for 5-7 days for limited lesions.
  • For MRSA concerns, clindamycin at 20 mg/kg/day in 3 divided doses for 7 days can be considered, as it is an important option for children.
  • Impetigo, caused primarily by Staphylococcus aureus and Streptococcus pyogenes, requires prompt treatment to prevent spread and complications.
  • Good hygiene practices, including daily bathing with antibacterial soap, keeping fingernails short, and avoiding sharing personal items, help prevent spread to other body areas and to other children. The 2014 guidelines provide the most up-to-date recommendations for the treatment of impetigo, and following these guidelines can help improve patient outcomes and reduce the risk of complications 1.

From the Research

Impetigo Pediatric Dosing

  • The treatment of impetigo in pediatric patients can be achieved through topical antibiotics for localized lesions, while oral antibiotics are reserved for extensive disease 2.
  • Topical antibiotics such as mupirocin, retapamulin, and fusidic acid are effective in treating impetigo, and may be superior to oral antibiotics in some cases 3, 4, 5.
  • Oral antibiotic therapy can be used for impetigo with large bullae or when topical therapy is impractical, with options including amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, and macrolides 3, 4, 6.
  • However, penicillin is not a recommended treatment option due to its limited effectiveness against certain strains of bacteria 3, 4.
  • Antimicrobial stewardship is critical to optimize patient outcomes and prevent the development of resistance, and healthcare providers should be aware of local resistance patterns in impetigo to guide therapy 2.

Treatment Considerations

  • The increasing prevalence of antibiotic-resistant bacteria, including methicillin-resistant S. aureus, macrolide-resistant streptococcus, and mupirocin-resistant streptococcus, has changed empiric treatment considerations 3.
  • Fusidic acid, mupirocin, and retapamulin are effective against methicillin-susceptible S. aureus and streptococcal infections, while clindamycin is helpful in suspected methicillin-resistant S. aureus infections 3.
  • Trimethoprim/sulfamethoxazole covers methicillin-resistant S. aureus infection, but is inadequate for streptococcal infection 3.

Future Directions

  • Newer safe and effective topical antibiotic alternatives should be considered as a first-line treatment to promote antimicrobial stewardship 2.
  • A systematic literature review and expert panel consensus statements can help guide the management of impetigo in the pediatric population 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.